Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis
- PMID: 26497483
- DOI: 10.1002/phar.1651
Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis
Erratum for
-
Vedolizumab for the treatment of moderately to severely active ulcerative colitis.Pharmacotherapy. 2015 Apr;35(4):412-23. doi: 10.1002/phar.1561. Pharmacotherapy. 2015. PMID: 25884529 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources